High-dose-rate interstitial brachytherapy for previously untreated cervical carcinoma.

Abstract:

PURPOSE:The aim of the study was to evaluate the results of high-dose-rate interstitial brachytherapy (HDR-ISBT) for patients with advanced cervical carcinoma in which intracavitary radiation therapy may result in a suboptimal dose distribution. METHODS AND MATERIALS:Between 1995 and 2005, 25 patients of median age 64 years were treated with external beam radiation therapy and HDR-ISBT. The International Federation of Gynecology and Obstetrics stages of the patients were I (4%), II (16%), III (68%), and IVA (12%). Whole pelvic irradiation of 30Gy/15 fractions was followed by HDR-ISBT of 30Gy/5 fractions/3 days. Subsequently, additional pelvic external beam radiation therapy of 20Gy/10 fractions was delivered with a midline block. The median followup period was 55 months. RESULTS:The actuarial 5-year progression-free survival and overall survival rates for all cases were 42% and 54%, respectively. For the 17 patients with a Stage III tumor, the 5-year local control and overall survival rates were 73% and 51%, respectively. Two patients (8%) developed late toxicities of Grade 3. CONCLUSIONS:A high rate of pelvic control and survival with acceptable level of late toxicities were obtained for patients with advanced cervical carcinoma treated with HDR-ISBT.

journal_name

Brachytherapy

journal_title

Brachytherapy

authors

Isohashi F,Yoshioka Y,Koizumi M,Konishi K,Sumida I,Takahashi Y,Ogata T,Morishige KI,Enomoto T,Kawaguchi Y,Kotsuma T,Adachi K,Fukuda S,Akino Y,Inoue T

doi

10.1016/j.brachy.2008.12.002

subject

Has Abstract

pub_date

2009-04-01 00:00:00

pages

234-239

issue

2

eissn

1538-4721

issn

1873-1449

pii

S1538-4721(08)00701-0

journal_volume

8

pub_type

杂志文章
  • Review of brachytherapy complications - Upper gastrointestinal tract.

    abstract::While brachytherapy applications are not widely used for cancer diagnoses in the upper GI tract (including the esophagus, liver, stomach, and pancreas), they have a clear role in palliation and symptom management and occasionally definitive locoregional treatment. With the increasing use of image-guided techniques, th...

    journal_title:Brachytherapy

    pub_type: 杂志文章,评审

    doi:10.1016/j.brachy.2020.11.010

    authors: Folkert MR,Gottumukkala S,Nguyen NT,Taggar A,Sur RK

    更新日期:2020-12-22 00:00:00

  • Unusually high prostate-specific antigen bounce after prostate brachytherapy: Searching for etiologic factors.

    abstract:PURPOSE:Determine whether fat distribution, body mass index, or clinical and dosimetric factors are associated with prostate specific antigen (PSA) bounce (PSAb) of ≥1.6 ng/mL in patients treated with permanent seed (125)I prostate brachytherapy (PB). METHODS AND MATERIALS:We identified 23 patients with a PSAb of ≥1.6...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2013.05.005

    authors: Chira C,Taussky D,Gruszczynski N,Meissner A,Larrivée S,Carrier JF,Donath D,Delouya G

    更新日期:2013-11-01 00:00:00

  • Phase I-II trial of perioperative high-dose-rate brachytherapy in oral cavity and oropharyngeal cancer.

    abstract:BACKGROUND:To determine the feasibility of combined perioperative high-dose-rate brachytherapy (PHDRB) and intermediate-dose external beam radiation therapy (EBRT) as an alternative to full-dose adjuvant EBRT in patients with unirradiated squamous cell cancer (SCC) of the oral cavity and oropharynx. METHODS AND MATERI...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2008.10.002

    authors: Martínez-Monge R,Gómez-Iturriaga A,Cambeiro M,Garrán C,Montesdeoca N,Aristu JJ,Alcalde J

    更新日期:2009-01-01 00:00:00

  • Palliative treatment by high-dose-rate intraluminal brachytherapy in patients with advanced esophageal cancer.

    abstract:PURPOSE:The aim of this work was to analyze the results of palliative HDR brachytherapy in patients with advanced esophageal cancer. METHODS AND MATERIALS:Ninety-one patients with unresectable, advanced esophageal cancer were treated palliatively by HDR brachytherapy. All patients received a total dose of 22.5 Gy in t...

    journal_title:Brachytherapy

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.brachy.2004.05.003

    authors: Skowronek J,Piotrowski T,Zwierzchowski G

    更新日期:2004-01-01 00:00:00

  • Process improvement for the safe delivery of multidisciplinary-executed treatments-A case in Y-90 microspheres therapy.

    abstract:PURPOSE:To develop a safe and robust workflow for yttrium-90 (Y-90) radioembolization procedures in a multidisciplinary team environment. METHODS AND MATERIALS:A generalized Define-Measure-Analyze-Improve-Control (DMAIC)-based approach to process improvement was applied to a Y-90 radioembolization workflow. In the fir...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2016.08.001

    authors: Cai B,Altman MB,Garcia-Ramirez J,LaBrash J,Goddu SM,Mutic S,Parikh PJ,Olsen JR,Saad N,Zoberi JE

    更新日期:2017-01-01 00:00:00

  • American Brachytherapy Society (ABS) consensus statement for sarcoma brachytherapy.

    abstract:PURPOSE:To present recommendations for the use of brachytherapy (BT) in patients with soft tissue sarcoma (STS). METHODS:A group of practitioners with expertise and experience in sarcoma BT formulated recommendations for BT in STS based on clinical experience and literature review. RESULTS:The indications for adjuvan...

    journal_title:Brachytherapy

    pub_type: 杂志文章,评审

    doi:10.1016/j.brachy.2012.12.002

    authors: Holloway CL,Delaney TF,Alektiar KM,Devlin PM,O'Farrell DA,Demanes DJ

    更新日期:2013-05-01 00:00:00

  • Efficacy of high-dose-rate interstitial brachytherapy in patients with oral tongue carcinoma.

    abstract:PURPOSE:To evaluate the results of high-dose-rate (HDR)-interstitial brachytherapy (ISBT) in oral tongue carcinomas. METHODS AND MATERIALS:Between September 1999 and August 2007, 50 patients were treated for oral tongue carcinoma with HDR-ISBT. The patient's mean age was 58 years. Forty-two patients were in T1-2 stage...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2009.10.003

    authors: Guinot JL,Santos M,Tortajada MI,Carrascosa M,Estellés E,Vendrell JB,Muelas R,Chust ML,Mengual JL,Arribas L

    更新日期:2010-07-01 00:00:00

  • Toward a dynamic real-time intraoperative permanent prostate brachytherapy methodology.

    abstract:PURPOSE:To evaluate dosimetry and source location relative to CT-based dosimetry when performing real-time dynamic permanent prostate brachytherapy (PPB) with inverse treatment planning. METHODS AND MATERIALS:A treatment algorithm for dynamic PPB was developed using inverse treatment planning. The technique utilizes r...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/S1538-4721(03)00134-X

    authors: Potters L,Calguaru E,Thornton KB,Jackson T,Huang D

    更新日期:2003-01-01 00:00:00

  • The effect of hormonal manipulation on urinary function following permanent prostate brachytherapy.

    abstract:PURPOSE:To evaluate the effect of hormonal manipulation on catheter dependency, the resolution of urinary symptomatology, and the need for postbrachytherapy transurethral/transincisional resection (TURP/TUIP). METHODS AND MATERIALS:Seven hundred sixteen consecutive patients (median follow-up, 29 months) underwent brac...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2003.12.001

    authors: Merrick GS,Butler WM,Wallner KE,Murray B,Allen Z,Lief JH,Galbreath RW

    更新日期:2004-01-01 00:00:00

  • Long-term efficacy and urological toxicity of low-dose-rate brachytherapy (LDR-BT) as monotherapy in localized prostate cancer.

    abstract:PURPOSE:The purpose of this study was to evaluate the incidence of late severe (≥Grade 3) urinary toxicity and the long-term efficacy after low-dose-rate brachytherapy (LDR-BT) in patients with localized prostate cancer (PCa). METHODS AND MATERIALS:During the years 1999-2008, 241 patients with PCa who underwent LDR-BT...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2019.05.005

    authors: Vuolukka K,Auvinen P,Palmgren JE,Voutilainen T,Aaltomaa S,Kataja V

    更新日期:2019-01-01 00:00:00

  • Comparison of outcome endpoints in intermediate- and high-risk prostate cancer after combined-modality radiotherapy.

    abstract:PURPOSE:To compare a standard radio-oncological and a surgical biochemical failure definition after combined-modality radiation therapy (CRT) in men with intermediate- and high-risk prostate cancer. METHODS:425 men were treated with external beam radiotherapy (59.4 Gy, 33 fractions) and 125J seed-brachytherapy (S-BT, ...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2019.09.001

    authors: Boehle A,Katic K,König IR,Robrahn-Nitschke I,Brandenburg B

    更新日期:2020-01-01 00:00:00

  • High-dose-rate brachytherapy as monotherapy for prostate cancer: The impact of cellular repair and source decay.

    abstract:PURPOSE:This work quantifies the influence of intrafraction DNA damage repair and cellular repopulation on biologically effective dose (BED) in Ir-192 high-dose-rate brachytherapy for prostate cancer. In addition, it examines the effect of source-decay-induced BED variation for patients treated at different time points...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2019.04.005

    authors: Tien CJ,Carlson DJ,Nath R,Chen ZJ

    更新日期:2019-01-01 00:00:00

  • High-dose-rate brachytherapy for localized prostate adenocarcinoma post abdominoperineal resection of the rectum and pelvic irradiation: Technique and experience.

    abstract:PURPOSE:Treatment options are limited for patients with localized prostate cancer and a prior history of abdominoperineal resection (APR) and pelvic irradiation. We have previously reported on the successful utility of high-dose-rate (HDR) brachytherapy salvage for prostate cancer failing definitive external beam radia...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2009.02.004

    authors: Jabbari S,Hsu IC,Kawakami J,Weinberg VK,Speight JL,Gottschalk AR,Roach M 3rd,Shinohara K

    更新日期:2009-10-01 00:00:00

  • Changes in brachytherapy-based APBI patient selection immediately before and after publication of the ASTRO consensus statement.

    abstract:PURPOSE:In July 2009, American Society of Radiation Oncology (ASTRO) released a consensus statement (CS) to guide patient selection for accelerated partial breast irradiation (APBI). The goal of this study was to examine how practice patterns changed following the guideline's release. METHODS:The Surveillance, Epidemi...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2015.03.003

    authors: Husain ZA,Lloyd S,Shah C,Wilson LD,Koshy M,Mahmood U

    更新日期:2015-07-01 00:00:00

  • Dose homogeneity analysis of adjuvant radiation treatment in surgically resected brain metastases: Comparison of IORT, SRS, and IMRT indices.

    abstract:PURPOSE:Although surgery remains a treatment option for symptomatic brain metastases, the need for adjuvant radiation after surgery is widely accepted as standard. Despite a multitude of randomized trials aimed at identifying the ideal radiation treatment plan for surgically resected metastases, the development of new ...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2020.11.004

    authors: Dahshan BA,Weir JS,Bice RP,Renz P,Cifarelli DT,Poplawski L,Hack J,Vargo JA,Cifarelli CP

    更新日期:2021-01-13 00:00:00

  • Radioactive gold grain implants in recurrent and locally advanced head-and-neck cancers.

    abstract:PURPOSE:The radioactive gold grain applicator and seeds offer the flexibility necessary for effective use in the treatment of difficult sites of head-and-neck cancers. This study reviews our experience with gold grain (198Au) implants in locally advanced head-and-neck cancer to demonstrate their efficacy and feasibilit...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/s1538-4721(02)00054-5

    authors: Ashamalla H,Rafla S,Zaki B,Ikoro NC,Ross P

    更新日期:2002-01-01 00:00:00

  • Five fraction accelerated partial breast irradiation using noninvasive image-guided breast brachytherapy: Feasibility and acute toxicity.

    abstract:PURPOSE:To improve efficiency, convenience, and cost, a prospective phase II trial was initiated to evaluate accelerated partial breast irradiation delivered with noninvasive image-guided breast brachytherapy (NIBB) via five once-daily fractions. METHODS AND MATERIALS:Women ≥50 years old with early-stage breast cancer...

    journal_title:Brachytherapy

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.brachy.2018.05.006

    authors: Hepel JT,Yashar C,Leonard KL,Einck JP,Sha S,DiPetrillo T,Wiggins D,Graves TA,Edmonson D,Brown University Oncology Research Group.,Wazer DE

    更新日期:2018-01-01 00:00:00

  • Monte Carlo calculation of the dose perturbations in a dual-source HDR/PDR afterloader treatment unit.

    abstract:PURPOSE:Currently, there are high dose rate afterloaders available that can drive two different radioactive sources simultaneously. The source-source and source-cable attenuations are not taken into account by current planning systems. The purpose of this work is to characterize these effects and their overall impact o...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2016.03.007

    authors: Collins-Fekete CA,Plamondon M,Verhaegen F,Beaulieu L

    更新日期:2016-07-01 00:00:00

  • Complications after 90Y microsphere radioembolization for unresectable hepatic tumors: An evaluation of 112 patients.

    abstract:PURPOSE:The aim of this study was to estimate the incidence of complications after (90)Y microsphere radioembolization for unresectable hepatic tumors and evaluate risk factors for late complications. METHODS AND MATERIALS:A cohort of 112 consecutive patients from two institutions underwent (90)Y microsphere radioembo...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2013.05.008

    authors: Peterson JL,Vallow LA,Johnson DW,Heckman MG,Diehl NN,Smith AA,Tzou KS,Paz-Fumagalli R,Kim S,Ko SJ,Daugherty LC,Kim GP,Brown N,Mori KW,Buskirk SJ

    更新日期:2013-11-01 00:00:00

  • Clinical outcomes with MRI-guided image-based brachytherapy in cervical cancer: An institutional experience.

    abstract:PURPOSE:To evaluate the long-term disease control and toxicity to the organs at risk after dose-escalated image-based adaptive brachytherapy (BT) in cervical cancer. METHODS AND MATERIALS:Sixty patients of cervical cancer were treated with external radiotherapy 46 Gy in 23 fractions with weekly cisplatin and MRI-guide...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2017.09.008

    authors: Simha V,Rai B,Patel FD,Kapoor R,Sharma SC,Singh OA,Singla V,Dhanireddy B,Ghoshal S

    更新日期:2018-01-01 00:00:00

  • Initial analysis of Pro-Qura: a multi-institutional database of prostate brachytherapy dosimetry.

    abstract:PURPOSE:The study aimed to analyze the Pro-Qura database in terms of patient implant sequence number for each institution to determine evidence for a dosimetric learning curve. METHODS AND MATERIALS:In the Pro-Qura database, 2833 of a total of 4614 postplans from 57 brachytherapists were analyzed for evidence of a dos...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2006.10.002

    authors: Merrick GS,Grimm PD,Sylvester J,Blasko JC,Butler WM,Allen ZA,Chaudhry UU,Mazza A,Sitter M

    更新日期:2007-01-01 00:00:00

  • Quantitative estimation of doses to salivary glands from using brachytherapy in head and neck cancers.

    abstract:PURPOSE:To quantify the percentage doses received by salivary glands (SGDs) in head and neck interstitial brachytherapy (BT). METHODS AND MATERIALS:The study included 43 patients who underwent high-dose rate iridium-192 implant for oral cavity and oropharyngeal lesions treated with BT as a boost. BT dose varied with d...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2010.03.001

    authors: Bhalavat RL,Vyas S,Jamema SV,Upreti R,Talole S,Medhi S

    更新日期:2011-01-01 00:00:00

  • Improved survival for patients with prostate cancer receiving high-dose-rate brachytherapy boost to EBRT compared with EBRT alone.

    abstract:PURPOSE:High-dose-rate (HDR) brachytherapy boost is a treatment of intermediate- to high-risk prostate cancer, but long-term clinical outcome data are sparse. We report long-term survival and toxicity data in a cohort of patients treated in a single institution. METHODS:Between 1998 and 2004, 654 patients with localiz...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2019.01.013

    authors: Kent AR,Matheson B,Millar JL

    更新日期:2019-01-01 00:00:00

  • Patient-reported sexual adjustment after definitive chemoradiation and MR-guided brachytherapy for cervical cancer.

    abstract:PURPOSE:The treatment of locally advanced cervical cancer with definitive chemoradiation (CRT) is associated with vaginal toxicity and altered sexual satisfaction. This prospective study assessed patient-reported sexual adjustment, vaginal dosimetry, and physician-reported vaginal toxicity in patients with cervical can...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2018.09.005

    authors: Conway JL,Gerber R,Han K,Jiang H,Xie J,Beiki-Ardakani A,Fyles A,Milosevic M,Williamson D,Croke J

    更新日期:2019-01-01 00:00:00

  • Clinical outcomes using image-guided interstitial brachytherapy for definitive cervical cancer patients with high-risk clinical target volumes greater than 30 cc.

    abstract:PURPOSE:Given the limited data using an interstitial approach with 3D-based planning for definitive cervical cancer utilizing the GEC-ESTRO defined high-risk clinical target volume (HR-CTV), we reviewed our institutional experience of cervical cancer patients with HR-CTVs ≥ 30 cc to determine whether our clinical and t...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2017.10.004

    authors: Wang C,Raince J,Swamy U,Park SJ,Zaide L,Mesko S,Demanes DJ,Kamrava M

    更新日期:2018-01-01 00:00:00

  • Salvage wide resection with intraoperative electron beam therapy or HDR brachytherapy in the management of isolated local recurrences of soft tissue sarcomas of the extremities and the superficial trunk.

    abstract:PURPOSE:To assess the toxicity and efficacy of salvage wide resection (SWR) with intraoperative electron beam radiation therapy (IOERT) or perioperative high-dose-rate brachytherapy (PHDRB) in previously unirradiated patients (PUP) vs. previously irradiated patients (PIP) with isolated local recurrence of soft tissue s...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2014.09.003

    authors: Cambeiro M,Aristu JJ,Moreno Jimenez M,Arbea L,Ramos L,San Julian M,Azinovic I,Calvo FA,Martínez-Monge R

    更新日期:2015-01-01 00:00:00

  • Trends in the utilization of adjuvant vaginal brachytherapy in women with early-stage endometrial carcinoma: Results of an updated period analysis of SEER data.

    abstract:PURPOSE:Adjuvant vaginal brachytherapy (VB) is a well-established and effective radiation treatment modality in women with early-stage endometrial carcinoma. We sought to evaluate and update published trends in the utilization of VB vs. other radiation therapy modalities (pelvic external beam radiation therapy (EBRT) o...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2016.06.012

    authors: Modh A,Ghanem AI,Burmeister C,Rasool N,Elshaikh MA

    更新日期:2016-09-01 00:00:00

  • Novel and programmatic improvements to the workflow associated with the AccuBoost breast brachytherapy procedure.

    abstract:PURPOSE:While the noninvasive breast brachytherapy (NIBB) treatment procedure, known as AccuBoost, for breast cancer patients is well established, the treatment quality can be improved by the efficiency of the workflow delivery. A formalized approach evaluated the current workflow through failure modes and effects anal...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2020.01.007

    authors: Roles SA,Hepel JT,Leonard KL,Wazer DE,Cardarelli GA,Schwer ML,Saleh ZH,Klein EE,Brindle JM,Rivard MJ

    更新日期:2020-01-01 00:00:00

  • Comparison of spinal and general anesthesia approaches for MRI-guided brachytherapy for cervical cancer.

    abstract:PURPOSE:To evaluate the impact of general versus spinal anesthesia on postprocedure narcotic use and of extradepartmental planning MRI on treatment time in high-dose-rate brachytherapy for cervical cancer. METHODS AND MATERIALS:Twenty-five patients (10 general anesthesia and 15 spinal anesthesia) who collectively rece...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2018.05.002

    authors: Frankart AJ,Meier T,Minges TL,Kharofa J

    更新日期:2018-01-01 00:00:00

  • Clinical factors and dosimetry associated with the development of prostate brachytherapy-related urethral strictures: A matched case-control study.

    abstract:PURPOSE:Urethral strictures are a rare complication of prostate brachytherapy (BXT), with prior studies showing radiation dose to the bulbomembranous urethra as being associated with stricture formation. This retrospective case-control study explored clinical and dosimetric parameters associated with the development of...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2017.04.242

    authors: Singhal S,Jamaluddin MF,Lee E,Sloboda RS,Parliament M,Usmani N

    更新日期:2017-01-01 00:00:00